0 seconds of 1 minute, 52 secondsVolume 0%
Press shift question mark to access a list of keyboard shortcuts
00:00
01:52
01:52
 
  • SQI Diagnostics (SQD) testing partner, KSL Diagnostics has received conditional approval for the EXACT COVID-19 Antibody Test
  • SQI Diagnostics CEO Andrew Morris sat down with Shoran Devi to discuss the news
  • The EXACT COVID-19 Antibody Test can detect an immune response in both vaccinated and previously COVID-19 infected people
  • SQI Diagnostics Inc is a Canada-based company engaged in developing and commercializing proprietary technologies & products for multiplexing diagnostics
  • SQI Diagnostics is up 2.86 per cent on the day trading at C$0.18 at 11:30 am EST

SQI Diagnostics (SQD) partner, KSL Diagnostics has received conditional approval from the New York State Department of Health for the EXACT COVID-19 Antibody Test.

Access to the EXACT COVID-19 Antibody Test will now be available to physicians and their patients in the United States through AZOVA Inc.

SQI Diagnostics CEO Andrew Morris sat down with Shoran Devi to discuss the news.

“The EXACT COVID-19 Antibody Test is the next generation of tools in the fight against COVID-19. It gives peace of mind because it can detect an immune response in both vaccinated and previously COVID-19 infected people. It also has the potential to give the health care system key insights and data into the relationship between antibody levels and breakthrough infections and reinfections. We’re bringing these tests to market now because we are determined to do our part to end the pandemic.”

SQI Diagnostics is a Canada-based company engaged in developing and commercializing proprietary technologies & products for multiplexing diagnostics.

SQI Diagnostics Inc. (SQD) is up 2.86 per cent on the day trading at C$0.18 at 11:30 am EST.

Latest News
More C.AYUR news on Stockhouse »
Latest Bullboard Posts
  • Trading today
    It seems to me someones wife wanted to go on vacation today,enjoy Cuba Who...
    March 4, 2025
  • Q2 results
    https://stockhouse.com/news/press-releases/2025/02/27/ayurcann-reports-another-record-sales-growth-in-q2-2025-of-13-363-509
    February 27, 2025
More bullboard posts for C.AYUR on Stockhouse »
More From The Market Online
Stock chart with arrow pointing down into the ground

@ the Bell: TSX tumbles again

The TSX plummeted on Friday, as a global selloff intensified due to China’s retaliatory measures against US tariffs.
AI generated stock market image

@ the Bell: TSX sinks under fears of reciprocal tariffs

The TSX dropped hard on Thursday, dragged down by energy and mining stocks, as reciprocal US tariffs heightened fears.
Covalon Technologies logo

Covalon Technologies to benefit from Trump tariffs

Covalon Technologies (TSXV:COV) believes it will benefit following U.S. President Trump's enforcement of reciprocal tariffs on Thursday.
stock image generated by AI

@ the Bell: TSX rallies in the face of “Liberation Day”

The TSX climbed in the final hours before “Liberation Day” tariffs were set to be implemented by the US to disrupt trade practices.